Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

RPR selects farnesyltransferase inhibitor for in vivo evaluation

May 12, 1997

Schering-Plough evaluates novel farnesyltransferase inhibitor

May 12, 1997

Antineoplastic/immunostimulating glycan discovered by U. of Illinois researchers

May 12, 1997

Modified p53 constructs prepared by the Wistar Institute

May 12, 1997

TAS-103 shows antitumor activity against orthotopically implanted human cancers

May 12, 1997

In vivo efficacy and pharmacokinetic profile of XR-9051

May 12, 1997

Positive preclinical results with CB-1267 in combination with 9-cis-RA for prostate cancer

May 12, 1997

D-21266 demonstrates advantages over miltefosine in vivo

May 12, 1997

New class of topo I inhibitors designed for oral administration

May 9, 1997

Novel EGF receptor TK inhibitor described by Mitsubishi

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...